CLINICAL NEWS
Researchers from the University of Washington have identified a threshold concentration of serum 25-hydroxyvitamin D [25-(OH)D] that is associated with increased risk for major medical events and say that season-specific targets may be more appropriate than static targets when evaluating health risk. » More |
CONTINUING EDUCATION
Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
EDITOR’S PICK
MTM by pharmacists helps resolve medication-related problems
In the patient-centered medical home, pharmacists who are practicing at the "top of their license" should be providing medication therapy management to detect, resolve, monitor, and prevent medication-related problems across the continuum of care for patients, according to a presentation at the American Pharmacists Association 2012 annual meeting and exposition in New Orleans. » Click here. |
Patients with schizophrenia who switched from haloperidol decanoate or fluphenazine decanoate to risperidone microspheres discontinued their treatment more frequently, according to a new study published in the March issue of the Journal of Clinical Psychiatry. » More |
A unique study designed to gauge the impact of polypharmacy on schizophrenia mortality produced some surprising results: The use of antidepressants or 2 or more antipsychotics was not associated with increased deaths, but the use of benzodiazepine was. » More |
Warfarin fared no better than aspirin at reducing the combined risk of brain hemorrhage, stroke, or death for heart-failure patients in normal rhythm, according to the results of a study published in the New England Journal of Medicine. » More |
Survey
a) Waste management
b) Patient risk assessment and education
c) Managing prior authorization of specialty products
d) Outcomes monitoring, reporting, and intervention
e) Helping patients navigate financial assistance programs
f) Adherence programs
Click here and see what your colleagues think, too.
Want to see the results of our last survey regarding healthcare industry trends and which one will have the most significant impact on the ability to manage pharmacy expenditures over the next 3-5 years? Click here. |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff |
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|